Cargando…

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing

Advanced therapy medicinal products (ATMP) are medicines for human use that are based on genes, cells or tissues. Over the past years, an increasing number of ATMP entered the market for treatment of cancer, genetic disorders, skeletal defects and metabolic diseases. However, the ATMP production met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, D.N., Chrobok, M., Ahlén, G., Blomberg, P., Sällberg, M., Pasetto, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650027/ https://www.ncbi.nlm.nih.gov/pubmed/36389443 http://dx.doi.org/10.1016/j.iotech.2022.100099

Ejemplares similares

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products
por: Silva, Daniela Nascimento, et al.
Publicado: (2022)

Process data of allogeneic ex vivo-expanded ABCB5(+) mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP
por: Ballikaya, Seda, et al.
Publicado: (2020)

Mini Cleanroom for the Manufacture of Advanced Therapy Medicinal Products (ATMP): Bioengineered Corneal Epithelium
por: Berisa-Prado, Silvia, et al.
Publicado: (2021)

Surgery Versus ATMPs: An Example From Ophthalmology
por: Magrelli, Federica M., et al.
Publicado: (2020)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing
por: Walcher, Lia, et al.
Publicado: (2021)

Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
por: Romagnoli, Luca, et al.
Publicado: (2011)

A Regulatory Risk-Based Approach to ATMP/CGT Development: Integrating Scientific Challenges With Current Regulatory Expectations
por: Salazar-Fontana, Laura I.
Publicado: (2022)

Evaluating Ecological Impact and Sustainability in the Manufacturing of Advanced Therapies: Comparative Analysis of Greenhouse Gas Emissions in the Production of ATMPs in Open and Closed Systems
por: Pinnetta, Giuseppe, et al.
Publicado: (2023)

Moving analytical ultracentrifugation software to a good manufacturing practices (GMP) environment
por: Savelyev, Alexey, et al.
Publicado: (2020)

Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective
por: Barker, Roger A., et al.
Publicado: (2021)

Approval of First CAR-Ts: Have we Solved all Hurdles for ATMPs?
por: Seimetz, Diane, et al.
Publicado: (2019)

EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation
por: Detela, Giulia, et al.
Publicado: (2019)

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
por: Sällberg, Matti, et al.
Publicado: (2020)

Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
por: Anyakora, Chimezie, et al.
Publicado: (2017)

Abstract 16 New Advanced Therapy Medicinal Products (ATMPs) in Medical Trials: A FamiCord Group Development Pipeline Update
por: Gerth, André, et al.
Publicado: (2022)

ATMP Environmental Exposure Assessment in European Healthcare Settings: A Systematic Review of the Literature
por: Damerval, Margaux, et al.
Publicado: (2021)

Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP)
por: Zscharnack, Matthias, et al.
Publicado: (2015)

Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
por: Chabner, Bruce A.
Publicado: (2010)

Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
por: Woods, Niamh, et al.
Publicado: (2020)

Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective
por: Muthu, Sathish, et al.
Publicado: (2022)

Development and Delphi validation of instrument for the preparation of a GMP audit of a cosmetic contract manufacturer in the UAE
por: Jairoun, Ammar Abdulrahman, et al.
Publicado: (2022)

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2015)

Burnout Stigma Inventory: Initial Development and Validation in Industry and Academia
por: May, Ross W., et al.
Publicado: (2020)

Hate and harassment in academia: the rising concern of the online environment
por: Oksanen, Atte, et al.
Publicado: (2021)

Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method
por: Andriolo, Gabriella, et al.
Publicado: (2018)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
por: Boudousquié, Caroline, et al.
Publicado: (2020)

RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe—Why the European Union Should Invest More!
por: Goldsobel, Gady, et al.
Publicado: (2021)

Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
por: McMullan, Christel, et al.
Publicado: (2023)

Sustainable Health Development Becoming Agenda for Public Health Academia
por: TAKIAN, Amirhossein, et al.
Publicado: (2016)

GMP/ISO quality audit manual for healthcare manufacturers and their suppliers /
por: Steinborn, Leonard
Publicado: (2003)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Leaving academia: PhD attrition and unhealthy research environments
por: Kis, Andrea, et al.
Publicado: (2022)

Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis
por: Fraser, Alasdair R., et al.
Publicado: (2017)

Madre academia
por: Prieto, Raúl
Publicado: (1977)

Academia honours
Publicado: (2004)

The interactomics of academia
por: Jacobs, Howy
Publicado: (2023)

Construction at Work: Multiple Identities Scaffold Professional Identity Development in Academia
por: Bentley, Sarah V., et al.
Publicado: (2019)

Strategic Ambiguity: How Pre-Tenure Faculty Negotiate the Hidden Rules of Academia
por: Cate, Leandra, et al.
Publicado: (2022)

Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
por: Bretaudeau, Laurent, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_59slmraudqeqiajl66l0vn0hm2